-+ 0.00%
-+ 0.00%
-+ 0.00%

Kane Biotech Signs Canadian Wound-Care Distribution Deal With Stevens Company

PUBT·10/20/2026 11:07:52
Listen to the news
Kane Biotech Signs Canadian Wound-Care Distribution Deal With Stevens Company
  • Kane Biotech signed a non-exclusive distribution agreement with The Stevens Company to expand Canadian access to its Health Canada-licensed revyve wound-care products.
  • Effective October 1, 2026, the agreement authorizes Stevens to resell wound gel in 1-ounce and 3-ounce formats, plus a 5-ounce spray.
  • Stevens’ distribution network will broaden access through hospitals, long-term care homes and community healthcare providers across Canada.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kane Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610200705PRIMZONEFULLFEED9848763) on October 20, 2026, and is solely responsible for the information contained therein.